Cargando…

Omalizumab in the prevention of anaphylaxis during immunotherapy: a case report

Omalizumab is approved for the treatment of chronic severe persistent asthma. As a trigger for anaphylaxis, the frequency of subcutaneous specific immunotherapy (SCIT) is high. We report the case of a 11-year-old boy with severe allergic asthma. During the initial phase of immunotherapy he experienc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stelmach, Iwona, Sztafińska, Anna, Woicka-Kolejwa, Katarzyna, Jerzyńska, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112270/ https://www.ncbi.nlm.nih.gov/pubmed/25097493 http://dx.doi.org/10.5114/pdia.2014.43192

Ejemplares similares

Omalizumab as a new therapeutic approach for children with severe asthma
por: Jerzyńska, Joanna, et al.
Publicado: (2014)

Quality of life in asthmatic children and their caregivers after two-year treatment with omalizumab, a real-life study
por: Sztafińska, Anna, et al.
Publicado: (2017)

Clinical and immunological effects of vitamin D supplementation during the pollen season in children with allergic rhinitis
por: Jerzyńska, Joanna, et al.
Publicado: (2016)

A 2-year-old girl with chronic crackles after respiratory syncytial virus infection: a case report
por: Woicka-Kolejwa, Katarzyna, et al.
Publicado: (2018)

Food allergy is associated with recurrent respiratory tract infections during childhood
por: Woicka-Kolejwa, Katarzyna, et al.
Publicado: (2016)

Children with severe asthma can start allergen immunotherapy after controlling asthma with omalizumab: a case series from Poland
por: Stelmach, Iwona, et al.
Publicado: (2015)

Allergic Rhinitis and House Dust Mite Sensitization Determine Persistence of Asthma in Children
por: Brzozowska, A., et al.
Publicado: (2022)

Effectiveness of omalizumab in children and adolescents with uncontrolled allergic asthma: a case series from Poland
por: Sztafińska, Anna, et al.
Publicado: (2021)

A Case of a Child With Several Anaphylactic Reactions to Drugs
por: Podlecka, Daniela, et al.
Publicado: (2019)

Omalizumab: Practical considerations regarding the risk of anaphylaxis
por: Kim, Harold L, et al.
Publicado: (2010)

Omalizumab ensures compatibility to bee venom immunotherapy (VIT) after VIT-induced anaphylaxis in a patient with systemic mastocytosis
por: Gülsen, Askin, et al.
Publicado: (2021)

Pediatric Asthma Caregiver’s Quality of Life Questionnaire is a useful tool for monitoring asthma in children
por: Stelmach, Iwona, et al.
Publicado: (2011)

The Bee Sting That Was Not: An Unusual Case of Hymenoptera Anaphylaxis Averted in a Patient Treated with Omalizumab for Asthma
por: Slaughter, Evelyn M., et al.
Publicado: (2014)

Impact of Omalizumab on Anaphylaxis in Patients Treated for Chronic Urticaria
por: Song, Xiaoting, et al.
Publicado: (2023)

Long-term omalizumab use in the treatment of exercise-induced anaphylaxis
por: Peterson, Mark R., et al.
Publicado: (2017)

Usefulness of sRtot and Rint in bronchodilator testing in the diagnosis of asthma in children
por: Bobrowska-Korzeniowska, Monika, et al.
Publicado: (2020)

Adolescent Athletes at Risk of Exercise-Induced Bronchoconstriction: A Result of Training or Pre-Existing Asthma?
por: Malewska-Kaczmarek, Kamila, et al.
Publicado: (2022)

Exhaled nitric oxide correlates with IL-2, MCP-1, PDGF-BB and TIMP-2 in exhaled breath condensate of children with refractory asthma
por: Brzozowska, Agnieszka, et al.
Publicado: (2015)

Predictors of deterioration of lung function in Polish children with cystic fibrosis
por: Olszowiec-Chlebna, Małgorzata, et al.
Publicado: (2016)

Severe exercise-induced anaphylaxis in a hot and humid area successfully treated with omalizumab: a case report
por: Mobayed, Hassan, et al.
Publicado: (2023)

Exercise-Induced Bronchoconstriction in Children: A Comparison between Athletes and Non-Athletes
por: Malewska-Kaczmarek, Kamila, et al.
Publicado: (2023)

Cytokine profiling in exhaled breath condensate after exercise challenge in asthmatic children with post-exercise symptoms
por: Majak, Paweł, et al.
Publicado: (2016)

Omalizumab induced Takotsubo syndrome: case report
por: Aguiar-Ricardo, Inês, et al.
Publicado: (2019)

Vitamins A and E during Pregnancy and Allergy Symptoms in an Early Childhood—Lack of Association with Tobacco Smoke Exposure
por: Gromadzinska, Jolanta, et al.
Publicado: (2018)

Anaphylaxis Associated With Allergen Specific Immunotherapy, Omalizumab, and Dupilumab: A Real World Study Based on the US Food and Drug Administration Adverse Event Reporting System
por: Bian, Sainan, et al.
Publicado: (2021)

Dose-dependence of protection from systemic reactions to venom immunotherapy by omalizumab
por: Boni, Elisa, et al.
Publicado: (2016)

Omalizumab in recurring larynx angioedema: a case report
por: Ozturk, Ayse Bilge, et al.
Publicado: (2014)

Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature
por: Ghazanfar, Misbah Nasheela, et al.
Publicado: (2015)

Sugammadex: Anaphylaxis: case report
Publicado: (2021)

Tozinameran: Anaphylaxis: case report
Publicado: (2022)

Patient-reported outcomes in urticarial vasculitis treated with omalizumab: case report
por: Cherrez-Ojeda, Ivan, et al.
Publicado: (2018)

Omalizumab for prevention of anaphylactic episodes in a patient with severe mosquito allergy
por: Meucci, Elisa, et al.
Publicado: (2021)

Anaphylaxis in the operating room treated with an anaphylaxis response kit: A case report
por: Shu, Akae, et al.
Publicado: (2023)

Home Environment in Early-Life and Lifestyle Factors Associated with Asthma and Allergic Diseases among Inner-City Children from the REPRO_PL Birth Cohort
por: Kapszewicz, Katarzyna, et al.
Publicado: (2022)

Combination of omalizumab and bee venom immunotherapy: does it work?
por: Yılmaz, İnsu, et al.
Publicado: (2018)

Omalizumab treatment in brittle asthma
por: Skiepko, Roman, et al.
Publicado: (2014)

Tropicamide and anaphylaxis: A case report
por: Sefi-Yurdakul, Nazife, et al.
Publicado: (2021)

Gadobutrol: Fatal anaphylaxis: case report
Publicado: (2021)

Tozinameran: Anaphylaxis: 2 case reports
Publicado: (2022)

Tozinameran: Anaphylaxis: 2 case reports
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5dv2ppf4e99vfm0kp6vh8jnmbh